R. Andreas Kraemer and Marlene Lange summarized the results regarding the importance ascribed to the actions taken by water providers to ensure the protection of water bodies and human health within current benchmarking approaches and new indicators to improve the representation of these actions.Read more
During this workshop a study regarding environmental and health-related indicators in the benchmarking of water suppliers conducted on behalf of the German Federal Environment Agency (UBA) was presented. Its results were discussed with experts from practice, policy and administration. The minutes of the workshop are available for download.
The EU has set itself ambitious objectives for combatting climate change. In addition to efforts to mitigate the impacts of climate change, the European Commission is also advancing efforts to strengthening climate adaptation in the EU, primarily by facilitating better exchange of information and practices as well as coordinating relevant activities such as in the case of trans-boundary impacts. Two...Read more
The Environmental Burden of Disease is part of the Global Burden of Disease methodology originally developed by the WHO and others. To use EBD estimates in Germany for environmental and health policy prioritisation, it is important to review them and to develop recommendations for adjustments that better reflect the German context. This project will conduct this review and aims to derive specific proposals for adjustments.
The EBD estimates the disease and mortality burden in a population that is attributable to a set of environmental risk factors. ToRead more
Over the last couple of decades, pharmaceutical products have been repeatedly found in environmental waters and even in drinking water. Although the effects of pharmaceuticals when ingested as medicine are well studied, the continuous ingestion of trace concentrations in water by the general population, or the effects for wildlife (e.g. fish), are only recently the subject of scientific research. This project addresses some of the knowledge gaps for this subject, targeting two specific compound groups: antibiotics, and anti-cancer (cytostatic) drugs.
There are goodRead more